PubMed:24583847
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-116 | Sentence | denotes | Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells. |
| TextSentencer_T2 | 117-324 | Sentence | denotes | VCAM-1 (CD106), a transmembrane glycoprotein, was first reported to play an important role in leukocyte adhesion, leukocyte transendothelial migration and cell activation by binding to integrin VLA-1 (α4β1). |
| TextSentencer_T3 | 325-554 | Sentence | denotes | In the present study, we observed that VCAM-1 expression can be induced in many breast cancer epithelial cells by cytokine stimulation in vitro and its up-regulation directly correlated with advanced clinical breast cancer stage. |
| TextSentencer_T4 | 555-792 | Sentence | denotes | We found that VCAM-1 over-expression in the NMuMG breast epithelial cells controls the epithelial and mesenchymal transition (EMT) program to increase cell motility rates and promote chemoresistance to doxorubicin and cisplatin in vitro. |
| TextSentencer_T5 | 793-1040 | Sentence | denotes | Conversely, in the established MDAMB231 metastatic breast cancer cell line, we confirmed that knockdown of endogenous VCAM-1 expression reduced cell proliferation and inhibited TGFβ1 or IL-6 mediated cell migration, and increased chemosensitivity. |
| TextSentencer_T6 | 1041-1191 | Sentence | denotes | Furthermore, we demonstrated that knockdown of endogenous VCAM-1 expression in MDAMB231 cells reduced tumor formation in a SCID xenograft mouse model. |
| TextSentencer_T7 | 1192-1300 | Sentence | denotes | Signaling studies showed that VCAM-1 physically associates with CD44 and enhances CD44 and ABCG2 expression. |
| TextSentencer_T8 | 1301-1495 | Sentence | denotes | Our findings uncover the possible mechanism of VCAM-1 activation facilitating breast cancer progression, and suggest that targeting VCAM-1 is an attractive strategy for therapeutic intervention. |
| T1 | 0-116 | Sentence | denotes | Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells. |
| T2 | 117-324 | Sentence | denotes | VCAM-1 (CD106), a transmembrane glycoprotein, was first reported to play an important role in leukocyte adhesion, leukocyte transendothelial migration and cell activation by binding to integrin VLA-1 (α4β1). |
| T3 | 325-554 | Sentence | denotes | In the present study, we observed that VCAM-1 expression can be induced in many breast cancer epithelial cells by cytokine stimulation in vitro and its up-regulation directly correlated with advanced clinical breast cancer stage. |
| T4 | 555-792 | Sentence | denotes | We found that VCAM-1 over-expression in the NMuMG breast epithelial cells controls the epithelial and mesenchymal transition (EMT) program to increase cell motility rates and promote chemoresistance to doxorubicin and cisplatin in vitro. |
| T5 | 793-1040 | Sentence | denotes | Conversely, in the established MDAMB231 metastatic breast cancer cell line, we confirmed that knockdown of endogenous VCAM-1 expression reduced cell proliferation and inhibited TGFβ1 or IL-6 mediated cell migration, and increased chemosensitivity. |
| T6 | 1041-1191 | Sentence | denotes | Furthermore, we demonstrated that knockdown of endogenous VCAM-1 expression in MDAMB231 cells reduced tumor formation in a SCID xenograft mouse model. |
| T7 | 1192-1300 | Sentence | denotes | Signaling studies showed that VCAM-1 physically associates with CD44 and enhances CD44 and ABCG2 expression. |
| T8 | 1301-1495 | Sentence | denotes | Our findings uncover the possible mechanism of VCAM-1 activation facilitating breast cancer progression, and suggest that targeting VCAM-1 is an attractive strategy for therapeutic intervention. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 49-53 | gene:960 | denotes | CD44 |
| T1 | 96-109 | disease:C0678222 | denotes | breast cancer |
| T2 | 49-53 | gene:960 | denotes | CD44 |
| T3 | 96-109 | disease:C0006142 | denotes | breast cancer |
| T4 | 14-20 | gene:7412 | denotes | VCAM-1 |
| T5 | 96-109 | disease:C0678222 | denotes | breast cancer |
| T6 | 14-20 | gene:7412 | denotes | VCAM-1 |
| T7 | 96-109 | disease:C0006142 | denotes | breast cancer |
| T8 | 364-370 | gene:7412 | denotes | VCAM-1 |
| T9 | 405-418 | disease:C0006142 | denotes | breast cancer |
| T10 | 364-370 | gene:7412 | denotes | VCAM-1 |
| T11 | 534-553 | disease:C2216702 | denotes | breast cancer stage |
| T12 | 364-370 | gene:7412 | denotes | VCAM-1 |
| T13 | 405-418 | disease:C0678222 | denotes | breast cancer |
| T14 | 1433-1439 | gene:7412 | denotes | VCAM-1 |
| T15 | 1379-1392 | disease:C0678222 | denotes | breast cancer |
| T16 | 1433-1439 | gene:7412 | denotes | VCAM-1 |
| T17 | 1379-1392 | disease:C0006142 | denotes | breast cancer |
| T18 | 1348-1354 | gene:7412 | denotes | VCAM-1 |
| T19 | 1379-1392 | disease:C0678222 | denotes | breast cancer |
| T20 | 1348-1354 | gene:7412 | denotes | VCAM-1 |
| T21 | 1379-1392 | disease:C0006142 | denotes | breast cancer |
| R1 | T0 | T1 | associated_with | CD44,breast cancer |
| R2 | T2 | T3 | associated_with | CD44,breast cancer |
| R3 | T4 | T5 | associated_with | VCAM-1,breast cancer |
| R4 | T6 | T7 | associated_with | VCAM-1,breast cancer |
| R5 | T8 | T9 | associated_with | VCAM-1,breast cancer |
| R6 | T10 | T11 | associated_with | VCAM-1,breast cancer stage |
| R7 | T12 | T13 | associated_with | VCAM-1,breast cancer |
| R8 | T14 | T15 | associated_with | VCAM-1,breast cancer |
| R9 | T16 | T17 | associated_with | VCAM-1,breast cancer |
| R10 | T18 | T19 | associated_with | VCAM-1,breast cancer |
| R11 | T20 | T21 | associated_with | VCAM-1,breast cancer |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 405-418 | HP_0003002 | denotes | breast cancer |
| T2 | 405-418 | HP_0100013 | denotes | breast cancer |
| T3 | 412-418 | HP_0002664 | denotes | cancer |
| T4 | 534-547 | HP_0003002 | denotes | breast cancer |
| T5 | 534-547 | HP_0100013 | denotes | breast cancer |
| T6 | 541-547 | HP_0002664 | denotes | cancer |
| T7 | 844-857 | HP_0003002 | denotes | breast cancer |
| T8 | 844-857 | HP_0100013 | denotes | breast cancer |
| T9 | 851-857 | HP_0002664 | denotes | cancer |
| T10 | 1143-1148 | HP_0002664 | denotes | tumor |
| T11 | 1379-1392 | HP_0003002 | denotes | breast cancer |
| T12 | 1379-1392 | HP_0100013 | denotes | breast cancer |
| T13 | 1386-1392 | HP_0002664 | denotes | cancer |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_24583847_3_0 | 642-679 | expanded | denotes | epithelial and mesenchymal transition |
| SS2_24583847_3_0 | 681-684 | abbr | denotes | EMT |
| AE1_24583847_3_0 | SS1_24583847_3_0 | SS2_24583847_3_0 | abbreviatedTo | epithelial and mesenchymal transition,EMT |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 24583847-0#14#20#gene7412 | 14-20 | gene7412 | denotes | VCAM-1 |
| 24583847-0#49#53#gene960 | 49-53 | gene960 | denotes | CD44 |
| 24583847-0#96#109#diseaseC0006142 | 96-109 | diseaseC0006142 | denotes | breast cancer |
| 24583847-0#96#109#diseaseC0678222 | 96-109 | diseaseC0678222 | denotes | breast cancer |
| 24583847-0#96#109#diseaseC0006142 | 96-109 | diseaseC0006142 | denotes | breast cancer |
| 24583847-0#96#109#diseaseC0678222 | 96-109 | diseaseC0678222 | denotes | breast cancer |
| 24583847-2#39#45#gene7412 | 364-370 | gene7412 | denotes | VCAM-1 |
| 24583847-2#209#228#diseaseC2216702 | 534-553 | diseaseC2216702 | denotes | breast cancer stage |
| 14#20#gene741296#109#diseaseC0006142 | 24583847-0#14#20#gene7412 | 24583847-0#96#109#diseaseC0006142 | associated_with | VCAM-1,breast cancer |
| 14#20#gene741296#109#diseaseC0678222 | 24583847-0#14#20#gene7412 | 24583847-0#96#109#diseaseC0678222 | associated_with | VCAM-1,breast cancer |
| 14#20#gene741296#109#diseaseC0006142 | 24583847-0#14#20#gene7412 | 24583847-0#96#109#diseaseC0006142 | associated_with | VCAM-1,breast cancer |
| 14#20#gene741296#109#diseaseC0678222 | 24583847-0#14#20#gene7412 | 24583847-0#96#109#diseaseC0678222 | associated_with | VCAM-1,breast cancer |
| 49#53#gene96096#109#diseaseC0006142 | 24583847-0#49#53#gene960 | 24583847-0#96#109#diseaseC0006142 | associated_with | CD44,breast cancer |
| 49#53#gene96096#109#diseaseC0678222 | 24583847-0#49#53#gene960 | 24583847-0#96#109#diseaseC0678222 | associated_with | CD44,breast cancer |
| 49#53#gene96096#109#diseaseC0006142 | 24583847-0#49#53#gene960 | 24583847-0#96#109#diseaseC0006142 | associated_with | CD44,breast cancer |
| 49#53#gene96096#109#diseaseC0678222 | 24583847-0#49#53#gene960 | 24583847-0#96#109#diseaseC0678222 | associated_with | CD44,breast cancer |
| 39#45#gene7412209#228#diseaseC2216702 | 24583847-2#39#45#gene7412 | 24583847-2#209#228#diseaseC2216702 | associated_with | VCAM-1,breast cancer stage |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2652 | 14-20 | gene:7412 | denotes | VCAM-1 |
| T2653 | 96-109 | disease:C0006142 | denotes | breast cancer |
| T2654 | 49-53 | gene:960 | denotes | CD44 |
| R1 | T2652 | T2653 | associated_with | VCAM-1,breast cancer |
| R2 | T2652 | T2653 | associated_with | VCAM-1,breast cancer |
| R3 | T2654 | T2653 | associated_with | CD44,breast cancer |
| R4 | T2654 | T2653 | associated_with | CD44,breast cancer |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 96-102 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T2 | 405-411 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T3 | 534-540 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T4 | 605-611 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T5 | 844-850 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T6 | 1379-1385 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T7 | 657-668 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 657-668 | http://purl.obolibrary.org/obo/UBERON_0003104 | denotes | mesenchymal |
| PD-UBERON-AE-B_T2 | 96-102 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T3 | 405-411 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T4 | 534-540 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T5 | 605-611 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T6 | 844-850 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T7 | 1379-1385 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T8 | 605-622 | http://purl.obolibrary.org/obo/UBERON_0008367 | denotes | breast epithelial |